Bicycle Therapeutics Plc (BCYC)
3.38
-0.18
(-5.06%)
USD |
NASDAQ |
Oct 02, 16:00
3.38
0.00 (0.00%)
After-Hours: 20:00
Bicycle Therapeutics Net Income (Quarterly) : -50.42M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -50.42M |
| March 31, 2026 | -60.72M |
| December 31, 2025 | -20.12M |
| September 30, 2025 | -58.73M |
| June 30, 2025 | -79.93M |
| March 31, 2025 | -60.99M |
| December 31, 2024 | -51.37M |
| September 30, 2024 | -51.32M |
| June 30, 2024 | -39.86M |
| March 31, 2024 | -26.55M |
| December 31, 2023 | -49.53M |
| September 30, 2023 | -49.61M |
| June 30, 2023 | -42.74M |
| March 31, 2023 | -39.42M |
| December 31, 2022 | -30.20M |
| September 30, 2022 | -28.11M |
| June 30, 2022 | -26.59M |
| March 31, 2022 | -27.41M |
| Date | Value |
|---|---|
| December 31, 2021 | -18.06M |
| September 30, 2021 | -14.61M |
| June 30, 2021 | -17.88M |
| March 31, 2021 | -16.25M |
| December 31, 2020 | -17.58M |
| September 30, 2020 | -10.32M |
| June 30, 2020 | -12.14M |
| March 31, 2020 | -11.33M |
| December 31, 2019 | -4.466M |
| September 30, 2019 | -9.423M |
| June 30, 2019 | -10.17M |
| March 31, 2019 | -6.572M |
| December 31, 2018 | -7.898M |
| September 30, 2018 | -7.704M |
| June 30, 2018 | -4.918M |
| March 31, 2018 | -2.551M |
| December 31, 2017 | -6.477M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Autolus Therapeutics Plc | -39.18M |
| Akari Therapeutics Plc | -4.816M |
| Cellectis SA | -21.79M |
| DBV Technologies SA | -- |
| Oxford Biomedica Plc | -- |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 0.6301M |
| Total Expenses (Quarterly) | 51.05M |
| EPS Diluted (Quarterly) | -0.7224 |
| Enterprise Value | -324.57M |
| Gross Profit Margin (Quarterly) | -69.64% |
| Profit Margin (Quarterly) | -8.00K% |
| Earnings Yield | -80.81% |
| Normalized Earnings Yield | -80.81 |